Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent
The potential use of amide-containing thiazoles, especially (2E,2Z)-3-allyl-4-[((E)-4-cinnamylpiperazin-1-yl)carbonyl]-2-[2-((E)-3-(furan-2-yl)propenylidene)hydrazono]-2,3-dihydrothiazole (1), as drugs for the treatment of Chagas disease has been recently described. The therapeutic application of 1...
- Autores:
-
Rodríguez, Gonzalo
Nargoli, Javier
López, Andrés
Moyna, Guillermo
Álvarez, Guzmán
Fernández, Marcelo
Osorio Martinez, Carlos Alberto
González, Mercedes Florencia
Cerecetto, Hugo Eduardo
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2017
- Institución:
- Corporación Universidad de la Costa
- Repositorio:
- REDICUC - Repositorio CUC
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cuc.edu.co:11323/1935
- Acceso en línea:
- https://hdl.handle.net/11323/1935
https://repositorio.cuc.edu.co/
- Palabra clave:
- Biodistributions
Chagas disease
Fluorescent probes
Fluorescent tracers
In-vitro
Pre-clinical
Proof of concept
Therapeutic Application
- Rights
- openAccess
- License
- Atribución – No comercial – Compartir igual